Loestrin 24 Fe- Drug Insight, 2019

Introduction
DelveInsight's pharmaceuticals report, "Loestrin 24 Fe Drug Insight, 2019" highlights the drug marketed details and the Global API Manufacturers details across the globe along with the location. The report covers the Global Market Assessment of the Loestrin 24 Fe covering the historical global sales and also provides the Loestrin 24 Fe sales estimation during the forecasted period (2019-2021). The report also covers the patents information and market exclusivity data, route of synthesis, market competition, and API manufacturers by country. In addition to this, the report also provides the SWOT analysis for Loestrin 24 Fe and emerging therapies in this space.

Methodology
The report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by DelveInsight`s team of industry experts.
Secondary sources information and data has been collected from various printable and non-printable sources like search engines, News websites, Government Websites, Trade Journals, White papers, Magazines, Trade associations, Books, Industry Portals, Industry Associations and access to available databases.

Scope
• A review of the Loestrin 24 Fe, based on information derived from company and industry-specific sources
• Product details on the basis of MOA, target, dosage, route of administration, molecule type, strength, Chemical type and ATC Classification
• Coverage of the Drug Master Files and API Manufacturers by country
• Patent Expiry Timeline and Exclusivity Details
• Route of Synthesis of the API
• Forecasted Sales Figure from 2019-2021
• Market competition and emerging therapies
• SWOT Analysis

Reasons to Buy
• Establish a comprehensive understanding of Loestrin 24 Fe
• Access to drug`s API manufacturers details to devise API procurement strategy for generic development
• Plan developmental timelines around drug`s patents for the major markets- US and EU
• Understand Loestrin 24 Fe`s current and future growth through its historical and forecasted sales
• Identify and understand the current in-market competitors for the drug
• Identify the product attributes and use it for target finding, drug repurposing, and precision medicine
• Identify and plan ahead for prospective emerging players and their products operating in the same space as the drug
• Identify opportunities in the same area as Loestrin 24 Fe with DelveInsight`s SWOT analysis

1. DelveInsight Report Introduction
2. Loestrin 24 Fe- Overview
• Product Description
• Route of Synthesis
• Mechanism of Action
• Pharmacology
• Pharmacodynamics
• Pharmacokinetics
• Adverse Reactions
• Regulatory Milestones by Region
• Deals and Partnerships
3. Product Details
4. Loestrin 24 Fe Sales Assessment
• Historical Sales
• Forecasted Sales
5. Patent Details
6. Global API Manufacturers Assessment
• Active Pharmaceutical Ingredient (API) Manufacturers by Country
• Active Pharmaceutical Ingredient (API) Manufacturers by Region
7. Market Competition
8. Emerging Therapies
8.1 Drug 1: Company 1
• Product Description
• Research and Development
• Product Development Activities
9. SWOT Analysis
Appendix
Methodology
Consulting Services
About DelveInsight
Contact Us
Disclaimer

List for Tables :

Table 1: Loestrin 24 Fe, Description
Table 2: Product Details
Table 3: Loestrin 24 Fe, Historical Sales till 2018 (in million USD)
Table 4: Loestrin 24 Fe, Forecasted Sales from 2019-2021 (in million USD)
Table 5: Patent Details
Table 6: API Manufacturers by country
Table 7: API Manufacturers by Region
Table 8: Loestrin 24 Fe Major Competitors
Table 9: Emerging Therapies

List for Figures :

Figure 1: Loestrin 24 Fe, Historical Global Sales till 2018 (in million USD)
Figure 2: Loestrin 24 Fe, Forecasted Global Sales from 2019-2021 (in million USD)
Figure 3: API Manufacturers by country
Figure 4: API Manufacturers by Region